Serving the Health Care Community in Michigan’s Upper Peninsula
New-Drug Reviews
    Uloric (febuxostat) (May 2009) 

    Renvela (sevelamer) (March 2009)

    Nplate (romiplostim) (January 2009)

    Cleviprex (clevidipine injectable emulsion)
    (November 2008)

    Entereg (alvimopan) (September 2008)

   
Drug-Class Reviews

   Hyperuricemia Agents  (May 2009)

   Proton Pump Inhibitors (May 2009)

   Beta Blockers (March 2009)

   Proton Pump Inhibitors (March 2009)

   Inhaled Anesthetics (November 2008)

   
Committee News
    Next Meeting:  July 15, 2009
    Packets mailed on or about July 8.
    May 13:  Last committee meeting.
   Thank you for participating.
    Uloric reviewed in May.
    Hyperuricemia agents reviewed in May.
    Proton pump inhibitors reviewed in May.
    Protocol for emergent warfarin reversal
   reviewed in May.
    Renvela reviewed in March.
    Beta blockers reviewed in March.
    Proton pump inhibitors reviewed in March.
    Nplate reviewed in January.
    Cleviprex reviewed in November.
    Inhaled anesthetics reviewed in November.
    Topical diclofenac reviewed in November.
    Low-molecular-weight heparins
   reviewed in November.
    Entereg reviewed in September.
    Fluoroquinolones reviewed in September.

  
   The UPHP and the UPHCN won a 2008
   Rx Benefit Innovation Award from the Pharmacy Benefit
   Management Institute in February. The award recognized both
   organizations for collaborating on the Community-Based
   Initiative to Manage Prescribing Cost and Quality.    

228 West Washington Street
Marquette, MI  49855
Telephone: (906) 225-7500  888-904-7526
Fax: (906) 225-7690

Webmaster

Disclaimer
A Collaboration of the Upper Peninsula Health Plan and the Upper Peninsula Health Care Network
Promoting Rational, Clinically Appropriate, Safe, and Cost-Effective Pharmaceutical Care in the Upper Peninsula

[Home] [Clinical] [The Committee] [Contact Us] [Links] [Policies]